| Net loss | -8.58M |
| Depreciation and amortization | 1.74M |
| Stock-based compensation expense | 776K |
| Write-off of intangibles | |
| Provision for excess and obsolete inventories | |
| Fair value of derivatives | |
| Accounts receivable | 32K |
| Inventories | 56K |
| Prepaid expenses and other current assets | -2K |
| Patents and licenses | -130K |
| Other assets | 30K |
| Accounts payable, accrued expenses and other current liabilities | |
| Net cash used in operating activities | |
| Purchases of property and equipment | 0 |
| Net cash used in investing activities | |
| Repurchase of common shares for withholding obligations | |
| Net proceeds from the sale of common stock | |
| Net cash provided by (used in) financing activities | |
| Net increase (decrease) in cash and cash equivalents | -4.07M |
| Cash and cash equivalents at beginning of period | 7.47M |
| Cash and cash equivalents at end of period | 3.4M |